Photo: close up of microscope


Laquinimod is a tablet that was initially developed for relapsing MS but is now being tested for primary progressive MS. In 2014 it was refused a license for relapsing MS due to disappointing trial results, and in 2017 a phase 3 trial was discontinued.

Current phase of trial: phase 2

Type of MS: primary progressive

Find out more about laquinimod